The last 15 years have brought great progress in the fight against malaria. Despite these advances, malaria still kills one child every two minutes. Additional efforts are needed to secure the gains and further accelerate progress toward malaria elimination. Bridging existing gaps in access to key interventions and introducing novel tools, including next-generation antimalarials, will be crucial to achieving this goal.
The Novartis Malaria Initiative is one of the healthcare industry's largest access-to-medicine programs. It focuses on improving access to treatment, helping communities in malaria-endemic countries deliver better healthcare and researching and developing next generation antimalarials.